DIVIS LAB TARGET PRICE NUVAMA
Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%
Shares of Divi’s Laboratories jumped 5% following a 64% YoY surge in Q2 FY27 net profit to Rs 1,127 crore. Brokerage Jefferies raised its target price by 23% to Rs 12,550, citing robust CDMO business expansion, strong EBITDA margins, and a solid GLP peptide pipeline.
Samvat 2083 outlook: 8 triggers that could turn Sensex, Nifty correction into a rally by next Diwali
Indian equities enter Samvat 2083 after a correction that has made valuations more attractive, but a sustained rally will depend on several triggers. Falling crude oil prices, easing inflation, an earnings recovery, FII buying, an India-US trade deal and continued domestic liquidity could shape the market's trajectory over the next year.
Divi's Labs shares jump 8% to fresh 52-week high after Q2 profit soars 64% YoY. What brokerages say after bumper results?
Divi’s Laboratories shares surged over 8% during Muhurat Trading, hitting a 52-week high after Q2 FY27 net profit jumped 64% to ₹1,127 crore. Revenue grew 35%, while brokerages differed on valuation concerns and future growth prospects.
Oil Price Today (November 9): Crude oil falls below $100 again as Trump says fresh attacks ‘highly unlikely’. What are experts saying?
Crude oil price: Prices came under further pressure after US President Donald Trump indicated that he was unlikely to authorise fresh attacks on Iran if negotiations to end the conflict continued to make progress. In a phone interview with CNN, Trump said further military action was "highly unlikely" to be necessary, provided both sides reached a strong agreement.
Oil falls on open as Trump says fresh Iran attacks 'unlikely'
Oil prices fell at Monday's open after US President Donald Trump said he was highly unlikely to order fresh attacks on Iran as long as talks to end the conflict progress, even as both countries reported that shipping had been hit in or near the Strait of
Global Market Today: Asian stocks open mostly higher, Nvidia probe looms
Benchmark stock indexes rose in Japan and Australia after a gauge of US semiconductor shares jumped 4.2% on Friday as speculation about possible tighter Democratic party regulation of the artificial intelligence industry eased. The MSCI Asia Pacific Index of equities gained 0.5%.
- Go To Page 1
Stocks in news: M&M, BHEL, Adani Enterprises, Wipro, Tata Steel, Siemens and Divi's Labs
Indian equity markets ended marginally lower on Sunday, breaking a seven-session winning streak. The NSE Nifty 50 decreased by 44 points, closing at 24,986. Several companies, including Adani Enterprises and Tata Steel, announced important corporate developments and new investments. Wipro appointed a new CEO for its Americas unit, while various firms reported their quarterly earnings. Overall, investors remain cautious as they monitor these announcements and future market movements.
Ahead of Market: 10 things that will decide stock market action on Monday
Sensex and Nifty ended lower during Muhurat Trading on November 8, snapping a six-session winning streak. Nifty slipped below 25,000 as investors booked profits. However, broader market sentiment remained positive, with 2,716 NSE stocks advancing against 736 declines.
Tata Steel shares jump 3% after Q2 profit rises 16% YoY. Should you buy, sell or hold?
Tata Steel shares surged over 3% during Muhurat Trading after Q2 FY27 net profit rose 16% year-on-year to nearly ₹3,700 crore. Revenue increased 11.5%, while brokerages maintained Buy ratings, citing improving margins and stronger second-half performance prospects.
Muhurat Trading 2026: Which stocks to buy during special session today? Analysts list top technical picks
Investors are preparing for the Muhurat Trading session today, which marks the beginning of Samvat 2083. Stock exchanges BSE and NSE will hold the session for an hour starting at 2.20 pm. Analysts from HDFC Securities and Axis Securities have identified several stocks as top picks for this trading period. Stocks like HCL Technologies and IIFL Finance have been highlighted for their potential upside.
Divi's Labs Q2 Results: PAT surges 64% YoY to Rs 1,127 crore; revenue jumps 35%
Divi's Laboratories has achieved a remarkable profit surge of 63.6% year-on-year for the September quarter of FY27, driven by a 35.4% increase in operational revenue, totaling Rs 3,676 crore. The company's total income reached Rs 3,770 crore in Q2FY27, while the first half of the fiscal year saw total earnings hit Rs 6,907 crore.
Kalyan, Titan, other Jewellery stocks rally up to 5% on Dhanteras 2026. How is yellow metal placed this festive season?
Jewellery stocks rallied ahead of Dhanteras 2026 as investors anticipated stronger precious metal demand. Meanwhile, brokerages see opportunities in gold and silver following their recent corrections, with Axis Securities and Religare Broking outlining accumulation ranges, price targets and key support levels.
Titan Company shares drop 3% after Q2 results. Why Emkay, Nuvama and others remain bullish
Titan shares declined despite a 54% rise in adjusted net profit for the September quarter. Strong demand for jewellery, watches, and eyewear supported performance, while brokerages remained largely positive on the stock, citing growth prospects, market-share gains, and improving margins.
Ather Energy shares fall 4%, snap 5-day gaining streak. What’s triggering the sharp fall?
Ather Energy shares ended a five-session winning streak as the shareholder lock-in period expired, making 21% of its outstanding equity eligible for trading. The development comes after the EV maker reported its first quarterly profit, while Nomura retained its Buy rating.
BSE shares jump 4% after Q2 results. Here’s what Bernstein, Motilal, others are saying
BSE shares rose sharply after the exchange reported a 44.9% year-on-year increase in Q2FY27 net profit to Rs 809 crore. Motilal Oswal maintained its Buy rating, Bernstein retained Underperform, while Nuvama continued with Hold. Here's what the three brokerages said about BSE's earnings and growth outlook.
ITC shares jump 6% in two days after Q2 results. More upside ahead?
ITC shares rose to Rs 283.5 apiece on NSE on Wednesday morning, the highest level seen by the stock in nearly three months. The stock has now recovered more than 12% in five sessions after hitting a 52-week low of Rs 253 apiece in late October.
Only 3.2% of working Indians trade stocks. Why Morgan Stanley likes NSE
Morgan Stanley has initiated coverage of NSE with an overweight rating and a price target of Rs 2,315, citing its dominant market share, strong liquidity and India’s underpenetrated capital markets. The brokerage expects revenue and normalised profit to grow at 15% annually between FY27 and FY29. It sees long-term growth opportunities but flags regulatory changes and market-share losses as key risks.
ITC shares rise 2% after Q2 results. What are Jefferies, Nuvama and others saying?
ITC shares gained 2% despite an 18.5% year-on-year decline in Q2 net profit, as higher taxes and falling cigarette earnings weighed on profitability. However, its FMCG business delivered strong growth. Jefferies, Nuvama, Emkay and DAM Capital remain positive on the stock, with target prices ranging from Rs 300 to Rs 355.
Missed Reliance Industries’ historic 12% one-day rally? Here’s what technical analysts are saying
Reliance Industries experienced a remarkable increase in share price after reporting impressive Q2 earnings, which significantly boosted its market capitalization. The firm’s net profit surged by 41% year-over-year, fueled by strong performances in its oil-to-chemicals and digital services segments. Analysts express optimism, with several brokerages setting ambitious target prices. Current technical indicators also reveal a favorable price trajectory, suggesting room for further growth following this positive oil sector performance.
Reliance Industries shares rally 6% after Q2 results. Here’s why Jefferies, others analysts see up to 47% upside
Reliance Industries shares rose up to 6% after the company reported a 41% YoY increase in Q2 net profit to Rs 25,548 crore, while revenue climbed 29% to Rs 3.32 lakh crore. The O2C business led earnings growth, with EBITDA surging 68% YoY to a record Rs 25,203 crore, supported by strong refining and petrochemical performance.
NTPC shares rise 3% after Q2 results. Why Jefferies and Nuvama remain bullish
NTPC shares rose after the state-owned power major reported a 14% YoY rise in standalone net profit to Rs 5,320 crore for Q2 FY27. Revenue grew 17% to Rs 45,752 crore, while EBITDA increased 9% to Rs 10,891 crore. The company also announced an interim dividend of Rs 3 per share, with November 6 set as the record date. Brokerages maintained their Buy ratings on the stock.
ITC Q2 Results Preview: Profit seen falling nearly 30% YoY as cigarette tax hikes bite
ITC is expected to report a weak Q2, with brokerages forecasting an 8% decline in cigarette volumes and a drop of up to 29% in cigarette operating profit following tax hikes. Nuvama expects consolidated revenue to fall 3% YoY and EBITDA to decline 20%. Growth in FMCG and paper businesses could provide some support against the pressure.
RIL Q2 Results Preview: Profit outlook brightens as O2C business set to drive growth
Reliance Industries is expected to report 15-17% year-on-year growth in September-quarter EBITDA, driven by a sharp recovery in its oil-to-chemicals business. Brokerages expect stronger refining margins, higher throughput and a weaker rupee to offset subdued retail and oil and gas performance. Investors will track O2C profitability, Jio Platforms’ earnings and retail margins as RIL announces results.
Suzlon Energy shares crash 10% as Nuvama, others slash target prices after Q2 margins disappoint. What lies ahead?
After Suzlon Energy's quarterly results for September were unveiled, its shares fell nearly 10%. The company faced a staggering 69% decline in net profit, despite enjoying a 26% increase in revenue from wind turbine deliveries. Nuvama raised flags regarding lower-than-expected EBITDA margins, likely influencing the stock's dip. Nonetheless, Centrum Broking maintains a 'Buy' rating, indicating potential for recovery.
Laurus Labs shares climb 4% after Q2 profit zooms 126% YoY
Laurus Labs shares rose 3.79% to Rs 2,329 after the pharmaceutical company reported strong Q2FY27 results. Revenue increased 33% year-on-year to Rs 2,206 crore, while net profit more than doubled to Rs 441 crore. Growth was supported by sustained momentum in its CDMO business and Affordable Medicines division, alongside improving margins and continued investments in manufacturing capabilities.
IndiGo shares rise 2% after Q2 losses narrow. What are Jefferies and other brokerages saying?
IndiGo shares gained 2% after the airline reported a narrower year-on-year Q2 loss of Rs 1,879 crore, although profitability remained under pressure from elevated fuel costs and rupee depreciation. Jefferies retained its Buy rating but cut its target price to Rs 5,650, while Nuvama maintained its Buy call with a revised target of Rs 5,435.
Trent shares soar 7% after Q2 results. Here’s why Elara Capital, Nuvama remain bullish on the Tata stock
Trent shares rallied after the retailer reported 25% year-on-year growth in Q2 FY27 profit and a 21.9% rise in revenue. Elara Capital upgraded the stock to Buy, while Nuvama maintained its positive stance and Systematix retained Hold.
Aerospace stock Aequs plunges 19% after Q2 results. Why are investors worried?
Aequs shares fell sharply on Tuesday after the aerospace manufacturer’s Q2 FY27 net loss more than doubled to Rs 52 crore. Revenue rose 45% year-on-year, but EBITDA fell 45% and margins narrowed. Brokerages flagged weakness in the consumer business and delayed breakeven expectations, even as the aerospace order book remained strong.
Load More
